These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 29713160)

  • 41. Developing a New Marker of Dynamic Hyperinflation in Patients with Obstructive Airway Disease - an observational study.
    Chuang ML; Hsieh MJ; Wu TC; Lin IF
    Sci Rep; 2019 May; 9(1):7514. PubMed ID: 31101856
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inspiratory capacity, dynamic hyperinflation, breathlessness, and exercise performance during the 6-minute-walk test in chronic obstructive pulmonary disease.
    Marin JM; Carrizo SJ; Gascon M; Sanchez A; Gallego B; Celli BR
    Am J Respir Crit Care Med; 2001 May; 163(6):1395-9. PubMed ID: 11371407
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dynamic hyperinflation during activities of daily living in COPD patients.
    Silva CS; Nogueira FR; Porto EF; Gazzotti MR; Nascimento OA; Camelier A; Jardim JR
    Chron Respir Dis; 2015 Aug; 12(3):189-96. PubMed ID: 25896955
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of beclomethasone/formoterol fixed combination on lung hyperinflation and dyspnea in COPD patients.
    Tzani P; Crisafulli E; Nicolini G; Aiello M; Chetta A; Clini EM; Olivieri D
    Int J Chron Obstruct Pulmon Dis; 2011; 6():503-9. PubMed ID: 22069361
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dynamic hyperinflation and dyspnea during the 6-minute walk test in stable chronic obstructive pulmonary disease patients.
    Satake M; Shioya T; Uemura S; Takahashi H; Sugawara K; Kasai C; Kiyokawa N; Watanabe T; Sato S; Kawagoshi A
    Int J Chron Obstruct Pulmon Dis; 2015; 10():153-8. PubMed ID: 25632228
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Airflow limitation or static hyperinflation: which is more closely related to dyspnea with activities of daily living in patients with COPD?
    Nishimura K; Yasui M; Nishimura T; Oga T
    Respir Res; 2011 Oct; 12(1):135. PubMed ID: 21988843
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Indacaterol therapy in moderate-to-severe chronic obstructive pulmonary disease: findings from a single-center primary care cohort.
    Singh MP
    Int J Chron Obstruct Pulmon Dis; 2013; 8():613-9. PubMed ID: 24353411
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Exacerbation recovery patterns in newly diagnosed or maintenance treatment-naïve patients with COPD: secondary analyses of TICARI 1 trial data.
    Mannino DM; Clerisme-Beaty EM; Franceschina J; Ting N; Leidy NK
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1515-1525. PubMed ID: 29785101
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The chronic obstructive pulmonary disease assessment test improves the predictive value of previous exacerbations for poor outcomes in COPD.
    Miravitlles M; García-Sidro P; Fernández-Nistal A; Buendía MJ; Espinosa de Los Monteros MJ; Esquinas C; Molina J
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2571-9. PubMed ID: 26664105
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hoover's sign is a predictor of airflow obstruction severity and is not related to hyperinflation in chronic obstructive pulmonary disease.
    Bruyneel M; Jacob V; Sanida C; Ameye L; Sergysels R; Ninane V
    Eur J Intern Med; 2011 Dec; 22(6):e115-8. PubMed ID: 22075295
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relationship between pulmonary hyperinflation and dyspnoea severity during acute exacerbations of cystic fibrosis.
    Nicholson TT; Barry PJ; Waterhouse DF; Nolan GM; McKone EF; Gallagher CG
    Respirology; 2017 Jan; 22(1):141-148. PubMed ID: 27614791
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Patients with chronic obstructive pulmonary disease and chronically colonized with Haemophilus influenzae during stable disease phase have increased airway inflammation.
    Tufvesson E; Bjermer L; Ekberg M
    Int J Chron Obstruct Pulmon Dis; 2015; 10():881-9. PubMed ID: 26005341
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The inspiratory capacity/total lung capacity ratio as a predictor of survival in an emphysematous phenotype of chronic obstructive pulmonary disease.
    French A; Balfe D; Mirocha JM; Falk JA; Mosenifar Z
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1305-12. PubMed ID: 26203237
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Spirometry for patients in hospital and one month after admission with an acute exacerbation of COPD.
    Rea H; Kenealy T; Adair J; Robinson E; Sheridan N
    Int J Chron Obstruct Pulmon Dis; 2011; 6():527-32. PubMed ID: 22069364
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dyspnea During Night-Time and at Early Morning in Patients with Stable COPD is Associated with Supine Tidal Expiratory Flow Limitation.
    Uccelli S; Pini L; Bottone D; Ranieri P; Orzes N; Tantucci C
    Int J Chron Obstruct Pulmon Dis; 2020; 15():2549-2558. PubMed ID: 33116471
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of endurance training on expiratory flow limitation and dynamic hyperinflation in patients with stable chronic obstructive pulmonary disease.
    Chen R; Chen R; Chen X; Chen L
    Intern Med J; 2014 Aug; 44(8):791-800. PubMed ID: 24860934
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of inspiratory capacity on dyspnea evaluation in COPD with or without emphysematous lesions: a pilot study.
    Cui L; Ji X; Xie M; Dou S; Wang W; Xiao W
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2823-2830. PubMed ID: 29033563
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Optimization of Nebulized Budesonide in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
    Zhang R; Zhu J; Liu Y; Li Y; Liu W; Zhang M; Chen B; Zhu S
    Int J Chron Obstruct Pulmon Dis; 2020; 15():409-415. PubMed ID: 32161453
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tiotropium and exercise training in COPD patients: effects on dyspnea and exercise tolerance.
    Ambrosino N; Foglio K; Balzano G; Paggiaro PL; Lessi P; Kesten S;
    Int J Chron Obstruct Pulmon Dis; 2008; 3(4):771-80. PubMed ID: 19281092
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The CAT (COPD Assessment Test) questionnaire as a predictor of the evolution of severe COPD exacerbations.
    García-Sidro P; Naval E; Martinez Rivera C; Bonnin-Vilaplana M; Garcia-Rivero JL; Herrejón A; Malo de Molina R; Marcos PJ; Mayoralas-Alises S; Ros JA; Valle M; Esquinas C; Barrecheguren M; Miravitlles M
    Respir Med; 2015 Dec; 109(12):1546-52. PubMed ID: 26542727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.